Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
... Amazon were acquiring a 10% stake in FLFL..
Amazon? That would be nice..
Interesting double trade after hours of over a million shares, one buy and the other unknown but at a buy price. Has the CFO finally bought some shares?!? We’d need to be told, but at least some positive sentiment to lift the gloom..
I like your optimism Putney, but if what you say is true, why is there no speculative buying?
Sadly that was back in May when the price was 8.7. Now the sp is nearly 40% lower. What we really need is a more than decent trading update..
Farewell to Jambon, an educated enthusiast. Perhaps he will resurrect himself with a new name. Hope so..
I’m not sure about that. The trades seem to be nearly all buys. Why would people buy when there is a doubt about trials? More likely manipulation or shorting. No doubt that the bod should think of lths and reassure the market. Seems ridiculously oversold on no news..
I think Springer may be springing..
Jambon, why lose faith? Your analysis of Koovs as a slow-burner heading in the medium term for a good rise has been well-researched and intelligently thought out. Don’t waver now, or lose patience..
https://www.thetimes.co.uk/article/astrazeneca-has-more-of-what-the-doctor-ordered-lmk7xwt22?shareToken=e7a60fd3504d2872f6bacf93e777ad41
Scroll to the second half..
I have been patient with this share for some while now, with over 150k shares invested, but am at a loss to understand why mms seem to keep the sp so low, in the face of what seems to be good positive news and the high likelihood of growing online interest in increasingly affluent India. Patience here may bear fruit, but there have been many dawns, and as yet few days..
Yes a weird share this, with a very large spread at times. Seems to be a punt for short term traders, buy under 700, sell over 725. Fundamentally showing huge potential, though, with now no debt problems and potentially exciting times ahead. Long term the rewards should be there, though, as so often with small pharma companies, the worm seems to turn slowly..
Yes I am a holder (average 18p). Good to hear your report of the meeting. Critics predictable, but they will no doubt change their tune soon enough, or, more likely and more desirably, fall silent..
This share is a slow burner. If you haven’t the patience to wait for it to bear fruit, you shouldn’t be in..
I agree. With all the supposed good news, the funding, and what I assumed was positive voting on the resolutions, down, down and down. At what point do we see the turnaround, or will there be some indication that all is not well?....
Can’t see why the director bought in if the price is going to do its customary downward drift between results/updates. Fill your boots...
Don’t like the look of that 2.5 million pound dump after hours yesterday. Hope it wasn’t a director...
Wasn’t funding supposed to have been secured by today? Has it happened (possible explanation of those buys today)? If so may there be an RMS early tomorrow? If not, then that’s surely not good news..
Worth holding onto also because a real possibility of a bid once (if!) Brexit sorted..